Healthcare Facilities and Services (TRBC)
-
Health
Trump administration pauses new rule limiting abortion referrals: report
FILE PHOTO: A Missouri state flag waves outside the Reproductive Health Services of Planned Parenthood St. Louis Region, Missouri’s sole…
Read More » -
Health
Illinois to defy Trump administration’s abortion referral ‘gag rule’
CHICAGO (Reuters) – Illinois will defy enforcement of the Trump administration’s rule barring taxpayer-backed family planning clinics from making abortion…
Read More » -
Health
CVS enters home dialysis care with clinical trial of new system
NEW YORK (Reuters) – CVS Health said on Wednesday it will start a clinical trial of its new home dialysis…
Read More » -
Health
Biden healthcare plan draws contrast with White House rivals
WASHINGTON (Reuters) – Democratic presidential front-runner Joe Biden unveiled a $750 billion healthcare plan on Monday that he said would…
Read More » -
Health
White House scraps key plan to lower U.S. drug prices; may target drugmakers
NEW YORK/WASHINGTON (Reuters) – The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine…
Read More » -
Health
White House scraps a proposal to lower U.S. drug prices
(Reuters) – The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing…
Read More » -
Health
White House kills rule aimed at ending Medicare drug rebates
(Reuters) – The Trump administration has withdrawn a rule aimed at eliminating pharmaceutical drug rebates from its Medicare health plans,…
Read More » -
Health
Trump administration pushes U.S. at-home kidney care, transplant availability
NEW YORK/WASHINGTON (Reuters) – The Trump administration on Wednesday set goals to move more kidney disease treatment into patients’ homes…
Read More » -
Health
Fresenius says tighter EU rules could trigger antibiotic shortage
FRANKFURT (Reuters) – German drugmaker Fresenius warned that stricter production norms being considered by Europe’s drug regulator could compound shortages…
Read More » -
Health
Lilly’s new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions
INDIANAPOLIS (Reuters) – Eli Lilly and Co has pulled ahead in a three-way race with Amgen Inc and Teva Pharmaceutical…
Read More »
